Category Archives: Z Medical centers

Under new leadership, Johns Hopkins creates a disaster at the Tampa children’s hospital

Dean and CEO of Johns Hopkins Medicine Paul Rothman December 11, 2018- by Steven E. Greer, MD Ranking colleges and medical centers is a futile, highly subjective, and ludicrous endeavor. Nevertheless,

Posted in - Policy, Cardiac surgery, Cardiology, Columbia, Johns Hopkins, Pediatrics | Leave a comment

Effects of Spaceflight on Astronaut Brain Structure as Indicated on MRI

November 22, 2017 – Interviewed by Steven E. Greer, MD We interviewed Donna Roberts, MD of the Medical University of South Carolina about her NEJM paper

Posted in - NEJM, Medical University of South Carolina, Neurology, Neurosurgery, Ophthalmology, Radiology | Leave a comment

Review of immunotherapy and targeted therapy

June 17, 2016- interviewed by Steven E. Greer, MD We interviewed Siwen Hu-Lieskovan MD, PhD of UCLA, an expert with immunotherapies for melanoma, to go over the

Posted in - Biotech, - Pharma, Oncology, UCLA | Leave a comment

Insurance companies are not paying for Repatha and Praluent

Update November 2, 2018- Amgen slashed the annual cost of this drug to $6,000.

Posted in - Biotech, - Pharma, - Policy, Cardiac surgery, Cardiology, Henry Ford, Primary care medicine | Leave a comment

The Deans of Johns Hopkins and Miami discuss ACO’s

February 28, 2011- By Steven E Greer, MD Dean Miller of Johns Hopkins and Dean Goldschmidt of Miami discuss accountable care organizations,

Posted in - Policy, CMS, Johns Hopkins | Leave a comment

Ocrelizumab (Ocrevus) versus Placebo in Primary Progressive Multiple Sclerosis

January 31, 2017- Interviewed by Steven E. Greer, MD

Posted in - Biotech, - NEJM, - Pharma, Neurology, Univ Texas | Leave a comment

Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma

February 27, 2017- interviewed by Steven E. Greer, MD We interviewed Joaquim Bellmunt, MD, PhD, the Director of the Bladder Cancer Center at Dana-Farber,

Posted in - Biotech, - NEJM, - Pharma, Harvard, Oncology | Leave a comment

The Miami Summit on Healthcare Spending Reduction

June 29, 2010 Produced and interviewed by Steven Greer, MD The Healthcare Channel and The University of Miami Health System hosted a roundtable discussion

Posted in - Policy, CMS, Congress, Univ Miami | Leave a comment

Book Review: Fat Chance by Robert H. Lustig, MD

February 9, 2013- by Steven E. Greer, MD How did our ancient ancestors evolve from being pure meat eating carnivore hunters into grain fed

Posted in - Reviews, books, devices, Bariatric surgery, FDA, Gastroenterology and liver, Internal Medicine, Pediatrics, Primary care medicine, UC San Francisco | Leave a comment

Does President Trump have “heart disease” based on his Coronary Calcium Score?

January 20, 2018- by Steven E. Greer, MD President Trump made news this week by having his doctor, Admiral Ronny Jackson, MD, answer

Posted in - NEJM, - Opinion, - Policy, Cardiac surgery, Cardiology, CDC, Emory, Internal Medicine, Neurosurgery, NIH | Leave a comment

Is Vitamin-D deficiency overdiagnosed?

November 8, 2016- Interviewed by Steven E. Greer, MD We interviewed JoAnn E. Manson, MD, DrPH, Chief, Division of Preventive Medicine,  Brigham

Posted in - NEJM, - Policy, CDC, Diabetes and endocrinology, FDA, Harvard, Primary care medicine | Leave a comment

The Daltrey Townshend teenage and young adult cancer center at UCLA

May 4, 2014- Interviewed by Steven E. Greer More than 20 years ago, Roger Daltrey began forming special cancer units in the UK to treat patients in their teenage

Posted in - Opinion, Oncology, Rehab, UCLA | Leave a comment

KIT inhibition by Gleevec (imatinib) for severe asthma

May 26, 2017- Interviewed by Steven E. Greer, MD Novartis’ Gleevec (imatinib) was approved in the U.S. in 2001 to treat leukemia. Now, researchers

Posted in - Biotech, - NEJM, - Pharma, National Jewish Health, Pulmonology | Leave a comment

Antoni Ribas, MD discusses cancer drugs targeting the PD1 signaling pathways

March 19, 2013- Interviewed by Steven E. Greer, MD The upcoming ASCO meeting will be dominated by numerous presentations relating to new

Posted in - Biotech, - Pharma, Oncology, UCLA | Leave a comment

Selective publication of positive trials on antidepressants

January 7, 2008- Interviewed and produced by Steven Greer, MD Erick Turner, MD, psychiatrist at Oregon Health and Science University and former FDA medical

Posted in Oregon Health and Science University, Psychology Psychiatry | Leave a comment

Violent video games and aggressive behavior

March 30, 2014- Interviewed by Steven E. Greer, MD A recent JAMA paper connects the dots between violent video games and aggressive behavior.

Posted in - JAMA, - Policy, Congress, Emergency medicine, Iowa State, Pediatrics, Psychology Psychiatry, Trauma Surgery | Leave a comment

The Gluten Crazies are out of control and affecting menus in restaurants

April 26, 2015- By Steven E. Greer, MD I was eating at a French restaurant recently, and the waiter asked me if I had any allergies, such as “gluten”.

Posted in - Opinion, Gastroenterology and liver, Harvard, Pediatrics | Leave a comment

Interview with Simon Townshend about the Daltrey/Townshend Teen Cancer Program

The Daltrey Townshend teenage and young adult cancer center at UCLA

Posted in Oncology, UCLA | Leave a comment

Bending the cost curve of cancer care

May 25, 2011- Since the approval of Genentech’s costly Avastin in 2004, prominent oncologists have warned that

Posted in - Biotech, - Pharma, CMS, Oncology, VCU | Leave a comment

Did Hillary Clinton really faint from “dehydration” or does she have a chronic neurological condition?

September 12, 2016- by Steven E. Greer, MD Once again, the Hillary Clinton campaign is on defense after another health scare from their

Posted in - Policy, Cardiology, Congress, Emergency medicine, Neurology, NYU, Ophthalmology, Primary care medicine, Radiology | Leave a comment